Skip to main content
Evome Medical Technologies Inc. logo

Evome Medical Technologies Inc. — Investor Relations & Filings

Ticker · EVMT ISIN · CA30053H1055 TSXV Manufacturing
Open in API
Filings indexed 403 across all filing types
Latest filing 2021-07-20 M&A Activity
Country CA Canada
Listing TSXV EVMT

About Evome Medical Technologies Inc.

https://www.evomemedical.com

Evome Medical Technologies Inc. is a medical device enterprise dedicated to the design, development, production, and distribution of specialized medical devices. The company's core business centers on human performance and rehabilitative solutions, specifically addressing the post-operative and recovery market. Evome aims to enhance patient outcomes through its portfolio of devices utilized in rehabilitation settings.

Recent filings

Filing Released Lang Actions
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing the execution of a non-binding Letter of Intent (LOI) for a potential acquisition by Salona Global Medical Device Corporation. It details the terms of the proposed acquisition, including financial figures, strategic rationale, and forward-looking statements. There is no indication that this is a full financial report, audit, or regulatory filing. It is not a transcript, earnings release, or management report. The content focuses on merger and acquisition activity, specifically the announcement of plans to acquire another business. Therefore, the document fits best under the category related to M&A activity announcements.
2021-07-20 English
Other.pdf
Regulatory Filings Classification · 100% confidence The document is a Form S-8 registration statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans. It includes detailed information about the securities to be registered, the plan under which they are offered, indemnification provisions, and references to other SEC filings. This is a regulatory filing related to securities registration, not a financial report, earnings release, or management discussion. It does not fit into categories like Annual Report, Earnings Release, or Capital Update. The Form S-8 is a specific SEC registration statement type, which falls under the general category of Regulatory Filings (RNS) in the provided classification scheme, as it is a compliance document and does not represent a financial report or announcement of voting results, management changes, or other specific categories.
2021-07-20 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and is described as a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the quarterly period ended May 31, 2021. It contains detailed unaudited condensed consolidated financial statements, including balance sheets, statements of operations, equity, cash flows, and notes. The length is substantial (15,000 characters), and it includes substantive financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). Q1 2022
2021-07-15 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification pursuant to SEC rules 13a-14(a) and 15d-14(a) related to a quarterly report on Form 10-Q for the period ended May 31, 2021. It is signed by the Interim CFO certifying the accuracy and completeness of the financial information and internal controls. The text is a certification letter and does not contain actual financial statements or substantive financial data itself. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than the quarterly report (IR) they reference. The document length is 3553 characters, which is relatively short and consistent with a certification letter rather than a full report.
2021-07-15 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification pursuant to SEC rules 13a-14(a) and 15d-14(a) related to a quarterly report on Form 10-Q for the period ended May 31, 2021. It is signed by an officer certifying the accuracy and completeness of the quarterly report and the effectiveness of internal controls. The text is a certification letter and does not contain actual financial data or the full quarterly report itself. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the quarterly report (IR). The document length is 3514 characters, which is relatively short and consistent with a certification letter rather than a full report.
2021-07-15 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and is described as a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the quarterly period ended May 31, 2021. It contains detailed unaudited condensed consolidated financial statements, including balance sheets, statements of operations, equity, cash flows, and notes. The length is approximately 15,000 characters, indicating a full report rather than a brief announcement. The presence of financial statements and management discussion confirms it is a comprehensive quarterly financial report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2021-07-15 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.